Pretreatment with transmyocardial revascularization might improve ischemic myocardial function performed with cell transplantation

Yanmei Wang, Hongmei Tang, Dong Wang, Ruofan Li, Yilong Dong, Wei Liu, Xiaodong Zhang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Cells transplanted into the myocardial infarct areas might be lost because of the lack of blood supply to these myocardium areas. The hypothesis that pretreatment with angiogenic therapy induced by transmyocardial revascularization (TMR) might improve ischemic myocardial function, followed by cell transplantation was tested. Methods and Results: After the ligation of the left anterior descending coronary artery, rats were treated with TMR. Two weeks, embryonic stem cells were transplanted into an injured heart. Four weeks after cell transplantation, cardiac function was assessed by homodynamic measurements. Capillary density and infarct size in the infarct myocardium were measured by using a previous experimental method. Graft histology and morphology was also evaluated. Four weeks after the operation, myocardial infarct (MI) rats treated with TMR and cell transplantation showed significantly higher cardiac function in hemodynamic measurements (p<0.01) than that of MI rats receiving cell transplantation or TMR alone. A significant increase in capillary density and reduction in infarct size was observed in the MI rats that received a combined therapy (p<0.01). Conclusion: Pretreatment of an infarct region of the heart with angiogenesis induced by TMR can enhance the efficacy of a cell graft and attenuate the progression of cardiac dysfunction in the rat model.

Original languageEnglish (US)
Pages (from-to)625-630
Number of pages6
JournalCirculation Journal
Volume70
Issue number5
DOIs
StatePublished - May 4 2006

Fingerprint

Cell Transplantation
Myocardial Infarction
Myocardium
Transplants
Embryonic Stem Cells
Ligation
Coronary Vessels
Histology
Hemodynamics
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Pretreatment with transmyocardial revascularization might improve ischemic myocardial function performed with cell transplantation. / Wang, Yanmei; Tang, Hongmei; Wang, Dong; Li, Ruofan; Dong, Yilong; Liu, Wei; Zhang, Xiaodong.

In: Circulation Journal, Vol. 70, No. 5, 04.05.2006, p. 625-630.

Research output: Contribution to journalArticle

Wang, Yanmei ; Tang, Hongmei ; Wang, Dong ; Li, Ruofan ; Dong, Yilong ; Liu, Wei ; Zhang, Xiaodong. / Pretreatment with transmyocardial revascularization might improve ischemic myocardial function performed with cell transplantation. In: Circulation Journal. 2006 ; Vol. 70, No. 5. pp. 625-630.
@article{d811fd6a02784c7c9735cbd660bf4734,
title = "Pretreatment with transmyocardial revascularization might improve ischemic myocardial function performed with cell transplantation",
abstract = "Background: Cells transplanted into the myocardial infarct areas might be lost because of the lack of blood supply to these myocardium areas. The hypothesis that pretreatment with angiogenic therapy induced by transmyocardial revascularization (TMR) might improve ischemic myocardial function, followed by cell transplantation was tested. Methods and Results: After the ligation of the left anterior descending coronary artery, rats were treated with TMR. Two weeks, embryonic stem cells were transplanted into an injured heart. Four weeks after cell transplantation, cardiac function was assessed by homodynamic measurements. Capillary density and infarct size in the infarct myocardium were measured by using a previous experimental method. Graft histology and morphology was also evaluated. Four weeks after the operation, myocardial infarct (MI) rats treated with TMR and cell transplantation showed significantly higher cardiac function in hemodynamic measurements (p<0.01) than that of MI rats receiving cell transplantation or TMR alone. A significant increase in capillary density and reduction in infarct size was observed in the MI rats that received a combined therapy (p<0.01). Conclusion: Pretreatment of an infarct region of the heart with angiogenesis induced by TMR can enhance the efficacy of a cell graft and attenuate the progression of cardiac dysfunction in the rat model.",
author = "Yanmei Wang and Hongmei Tang and Dong Wang and Ruofan Li and Yilong Dong and Wei Liu and Xiaodong Zhang",
year = "2006",
month = "5",
day = "4",
doi = "10.1253/circj.70.625",
language = "English (US)",
volume = "70",
pages = "625--630",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "5",

}

TY - JOUR

T1 - Pretreatment with transmyocardial revascularization might improve ischemic myocardial function performed with cell transplantation

AU - Wang, Yanmei

AU - Tang, Hongmei

AU - Wang, Dong

AU - Li, Ruofan

AU - Dong, Yilong

AU - Liu, Wei

AU - Zhang, Xiaodong

PY - 2006/5/4

Y1 - 2006/5/4

N2 - Background: Cells transplanted into the myocardial infarct areas might be lost because of the lack of blood supply to these myocardium areas. The hypothesis that pretreatment with angiogenic therapy induced by transmyocardial revascularization (TMR) might improve ischemic myocardial function, followed by cell transplantation was tested. Methods and Results: After the ligation of the left anterior descending coronary artery, rats were treated with TMR. Two weeks, embryonic stem cells were transplanted into an injured heart. Four weeks after cell transplantation, cardiac function was assessed by homodynamic measurements. Capillary density and infarct size in the infarct myocardium were measured by using a previous experimental method. Graft histology and morphology was also evaluated. Four weeks after the operation, myocardial infarct (MI) rats treated with TMR and cell transplantation showed significantly higher cardiac function in hemodynamic measurements (p<0.01) than that of MI rats receiving cell transplantation or TMR alone. A significant increase in capillary density and reduction in infarct size was observed in the MI rats that received a combined therapy (p<0.01). Conclusion: Pretreatment of an infarct region of the heart with angiogenesis induced by TMR can enhance the efficacy of a cell graft and attenuate the progression of cardiac dysfunction in the rat model.

AB - Background: Cells transplanted into the myocardial infarct areas might be lost because of the lack of blood supply to these myocardium areas. The hypothesis that pretreatment with angiogenic therapy induced by transmyocardial revascularization (TMR) might improve ischemic myocardial function, followed by cell transplantation was tested. Methods and Results: After the ligation of the left anterior descending coronary artery, rats were treated with TMR. Two weeks, embryonic stem cells were transplanted into an injured heart. Four weeks after cell transplantation, cardiac function was assessed by homodynamic measurements. Capillary density and infarct size in the infarct myocardium were measured by using a previous experimental method. Graft histology and morphology was also evaluated. Four weeks after the operation, myocardial infarct (MI) rats treated with TMR and cell transplantation showed significantly higher cardiac function in hemodynamic measurements (p<0.01) than that of MI rats receiving cell transplantation or TMR alone. A significant increase in capillary density and reduction in infarct size was observed in the MI rats that received a combined therapy (p<0.01). Conclusion: Pretreatment of an infarct region of the heart with angiogenesis induced by TMR can enhance the efficacy of a cell graft and attenuate the progression of cardiac dysfunction in the rat model.

UR - http://www.scopus.com/inward/record.url?scp=33646101245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646101245&partnerID=8YFLogxK

U2 - 10.1253/circj.70.625

DO - 10.1253/circj.70.625

M3 - Article

VL - 70

SP - 625

EP - 630

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 5

ER -